Does opioid substitution treatment have a protective effect on the clinical manifestations of COVID-19? Comment on Br J Anaesth 2020; 125: e382-3.

Eagleton, Marie; Stokes, Siobhan; Fenton, Fiona; Keenan, Eamon

Eagleton, Marie; Stokes, Siobhan; Fenton, Fiona; Keenan, Eamon.

Afiliação

Eagleton M; HSE National Drug Treatment Centre, Dublin, Ireland. Electronic address: meagleton@dtcb.ie.
Stokes S; HSE National Drug Treatment Centre, Dublin, Ireland.
Fenton F; HSE National Drug Treatment Centre, Dublin, Ireland.
Keenan E; Addiction Services National Social Inclusion Office, Health Service Executive, Dublin, Ireland.

Br J Anaesth ; 126(3): e114-e116, 2021 03.

Article em En | MEDLINE | ID: mdl-33358041

Assuntos

COVID-19; Pandemias; Analgésicos Opioides; Humanos; Tratamento de Substituição de Opiáceos; SARS-CoV-2

Palavras-chave

COVID-19; immunomodulation; inflammation; opioid substitution treatment; opioid use disorder

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Pandemias / COVID-19 Limite: Humans Idioma: En Revista: Br J Anaesth Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google